➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Merck
McKinsey
Mallinckrodt
Dow
Colorcon

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: SUCCINYLCHOLINE CHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

SUCCINYLCHOLINE CHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sandoz Inc ANECTINE succinylcholine chloride INJECTABLE;INJECTION 008453 NDA Sandoz Inc 0781-3411-95 10 VIAL, MULTI-DOSE in 1 CARTON (0781-3411-95) > 10 mL in 1 VIAL, MULTI-DOSE (0781-3411-70)
Sandoz Inc ANECTINE succinylcholine chloride INJECTABLE;INJECTION 008453 NDA Sandoz Inc 0781-9053-95 10 VIAL, MULTI-DOSE in 1 CARTON (0781-9053-95) > 10 mL in 1 VIAL, MULTI-DOSE (0781-9053-70)
Hospira QUELICIN succinylcholine chloride INJECTABLE;INJECTION 008845 NDA Hospira, Inc. 0409-6629-02 25 VIAL, MULTI-DOSE in 1 TRAY (0409-6629-02) > 10 mL in 1 VIAL, MULTI-DOSE (0409-6629-12)
Hospira QUELICIN succinylcholine chloride INJECTABLE;INJECTION 008845 NDA Hospira, Inc. 0409-6629-25 25 VIAL, MULTI-DOSE in 1 TRAY (0409-6629-25) > 10 mL in 1 VIAL, MULTI-DOSE (0409-6629-35)
Hospira QUELICIN succinylcholine chloride INJECTABLE;INJECTION 008845 NDA HF Acquisition Co LLC, DBA HealthFirst 51662-1353-1 10 mL in 1 VIAL, MULTI-DOSE (51662-1353-1)
Hospira QUELICIN PRESERVATIVE FREE succinylcholine chloride INJECTABLE;INJECTION 008845 NDA Hospira, Inc. 0409-6629-02 25 VIAL, MULTI-DOSE in 1 TRAY (0409-6629-02) > 10 mL in 1 VIAL, MULTI-DOSE (0409-6629-12)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Boehringer Ingelheim
McKesson
Moodys
Merck